Pharmaceuticals
10 clinical pharmacology experts
These ten professionals have led clinical pharmacology inside drug developers, with titles such as head of clinical pharmacology and executive director of clinical pharmacology. A reader can learn how in-house clinical pharmacology teams shape drug development programs.
Professionals to explore
01—10Anther Keung
LinkedInExperience: Vice President, Clinical Pharmacology · Boston Pharmaceuticals
Vice President, Clinical Pharmacology at Boston Pharmaceuticals since 2025, where the profile says this person leads strategic, scientific and operational clinical pharmacology across all programs and represents the department on cross-functional program teams. Former Executive Director, Clinical Pharmacology at Arvinas (2020–2022) and Senior Director Clinical Pharmacology at Ironwood Pharmaceuticals (2017–2020).
Brian James Schmidt
LinkedInExperience: Executive Director, Clinical Pharmacology · Madrigal Pharmaceuticals
Executive Director, Clinical Pharmacology at Madrigal Pharmaceuticals since 2024, a role the profile describes as the foundational clinical pharmacology hire at a growing pharmaceutical company. Former Executive Director, Head Quantitative Systems Pharmacology & Physiologically Based Pharmacokinetics at Bristol Myers Squibb (2022–2024).
Caly Chien
LinkedInExperience: Executive Director - Global Clinical Pharmacology · HUTCHMED
Former Executive Director - Global Clinical Pharmacology at HUTCHMED (2019–2025), and Clinical Pharmacology Lead Sub-Head at Kyowa Kirin, Inc.- U.S. since 2025. Former Scientific Director, Clinical Pharmacology & Pharmacometrics at Janssen, Pharmaceutical Companies of Johnson and Johnson (2014–2019). The profile says this person contributed to the development and FDA approval of apalutamide (ERLEADA®) and fruquintinib.
John D. Davis
LinkedInExperience: Vice President, head of Clinical Pharmacology · Regeneron
Vice President, head of Clinical Pharmacology at Regeneron since 2023, and former Executive Director, Clinical Pharmacology there (2019–2023). Former Associate Director, Clinical Pharmacology at Genentech (2011–2014) and Executive Director, Clinical Pharmacology at Pfizer (1996–2011). The profile lists regulatory interactions on clinical pharmacology issues with FDA, EMA, Health Canada and PMDA.
Karthik Venkatakrishnan
LinkedInExperience: Vice President, Global Head of Clinical Pharmacology and Quantitative Pharmacology · AstraZeneca
Vice President, Global Head of Clinical Pharmacology and Quantitative Pharmacology at AstraZeneca since 2026, where the profile says this person leads the Clinical Pharmacology and Quantitative Pharmacology (CPQP) organization. Former Senior Director and Head of Oncology Clinical Pharmacology (2013–2019) and Director, Clinical Pharmacology (Oncology) (2007–2013) at Takeda.
Peter Stopfer
LinkedInExperience: Global Head of Clinical Pharmacology · Boehringer Ingelheim
Former Global Head of Clinical Pharmacology at Boehringer Ingelheim (2022–2025), and Corporate SVP and Head of global Clinical Pharmacology and Non-clinical Safety Sciences there since 2025. Former Head Global Clin PK PD (2010–2022), Head clin PK PD (2009–2010) and Project clinical Pharmacokineticist (2004–2010) at Boehringer Ingelheim.
Rajendra S. Pradhan
LinkedInExperience: VP, Head of Clinical Pharmacology and Safety Sciences-CPSS at Alexion, AstraZeneca · AstraZeneca
VP, Head of Clinical Pharmacology and Safety Sciences-CPSS at Alexion, AstraZeneca since 2021. Former Executive Director, Clinical Pharmacology and DMPK at Alexion Pharmaceuticals, Inc. (2013–2021), Director of Clinical Pharmacology and Pharmacometrics in Immunology and Oncology at Abbott (1997–2013), and Pharmacometric and Pharmacokinetic Reviewer Office of Clinical Pharmacology & Biopharmaceutics at FDA (1995–1997).
Saileta Prabhu
LinkedInExperience: Senior Director, Clinical Pharmacology · Regeneron
Senior Director, Clinical Pharmacology at Regeneron since 2022, where the profile says this person leads clinical pharmacology strategy and execution from early development to late stage across therapeutic areas including obesity, oncology and rare diseases. Former Vice President, Clinical Biomarker Development at Takeda (2020–2022) and Senior Director, Preclinical & Translational PKPD at Genentech (2003–2020).
William D. Hanley
LinkedInExperience: VP, Global Head of Clinical Pharmacology & Pharmacometrics · BeOne Medicines
VP, Global Head of Clinical Pharmacology & Pharmacometrics at BeOne Medicines since 2024; the profile describes leading clinical pharmacology, pharmacometrics, modeling and simulation, DMPK and translational PK/PD. Former Vice President, Global Head of Quantitative Pharmacology and Disposition at Seagen (2021–2024) and Group Leader, Clinical Pharmacology at Genentech (2015–2018).
Zancong Shen
LinkedInExperience: Executive Director, Clinical Pharmacology · Arthrosi Therapeutics, Inc.
Executive Director, Clinical Pharmacology at Arthrosi Therapeutics, Inc. since 2024, and former Senior Director, Clinical Pharmacology there (2019–2024). The profile says this person plans and designs phase 1, 2 and 3 studies, interprets PK and PD data and represents the clinical pharmacology function in pipeline development. Former Director, Clinical Pharmacology at La Jolla Pharmaceutical Company (2017–2019).
Choose the right perspective
Match the person's setting to yours, since building a first clinical pharmacology function at a small biotech differs from leading a global group at a large drug maker. Also decide whether your question is mainly about study design, modeling and simulation or regulatory interactions, and pick someone whose roles centered on that work.
Questions to take into the conversation
- 01Which clinical pharmacology studies do you plan first for a new molecule, and how do you sequence the rest?
- 02How do you use modeling and simulation to support dose selection?
- 03How do you prepare clinical pharmacology sections of a regulatory submission so they hold up to review?
Reaching clinical pharmacology experts
How can I contact one of these clinical pharmacology experts?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 8 companies, including Boston Pharmaceuticals, Madrigal Pharmaceuticals and HUTCHMED, based on profile data retrieved on October 4, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach clinical pharmacology experts?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal